HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 81 filers reported holding HARPOON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2 | – | 3,743 | +322.9% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 885 | -83.6% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 5,397 | -1.9% | 0.00% | – |
| Q3 2022 | $5,000 | -44.4% | 5,501 | +12.1% | 0.00% | – |
| Q2 2022 | $9,000 | +200.0% | 4,909 | +1124.2% | 0.00% | – |
| Q4 2021 | $3,000 | -96.2% | 401 | -91.7% | 0.00% | – |
| Q4 2020 | $80,000 | +263.6% | 4,845 | +271.3% | 0.00% | – |
| Q3 2020 | $22,000 | – | 1,305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $2,335,957 | 1.93% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $2,329,753 | 0.97% |
| MPM BioImpact LLC | 3,196,707 | $2,378,350 | 0.62% |
| Lion Point Capital, LP | 169,283 | $125,980 | 0.05% |
| Artal Group S.A. | 1,000,000 | $744 | 0.04% |
| Cormorant Asset Management, LP | 540,600 | $402 | 0.03% |
| KENNEDY CAPITAL MANAGEMENT LLC | 529,934 | $394,377 | 0.01% |
| Orbimed Advisors | 621,218 | $462,310 | 0.01% |
| Tekla Capital Management LLC | 259,910 | $193,425 | 0.01% |
| CM WEALTH ADVISORS LLC | 50,354 | $29 | 0.01% |